Tata India Pharma & Healthcare Fund Regular Growth

+

Invest

Explore On

Equity
Sector - Healthcare
Rating N.A.
Plan

30.43 +0.02 (0.06%) NAV as on 12 Dec, 2025

5D
1M
6M
1Y
5Y
MAX

Key Metrics

AUM (in Cr)1338.85
CAGR -0.19%
Exit Load0.25%
Expense ratio2.10%
CategoryEquity
Min Investment5000
Min SIP100
Launch Date2015-12-28

Asset Allocation

Holdings As On - 16 December 2025

Holdings

Sectors

Name
Value (Cr)
Holding %

Abbott India
67.51
5.04%

IPCA Laboratories
53.46
3.99%

Cipla
53.00
3.96%

Lupin
47.75
3.57%

Ajanta Pharma
46.15
3.45%

Peer Comparison

Fund Name
UTI Healthcare Fund Regular Plan Growth-0.37%
Tata India Pharma & Healthcare Fund Regular Growth-0.19%
Mirae Asset Healthcare Fund Regular Growth0.83%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth-0.36%
HDFC Pharma and Healthcare Fund Regular Growth5.22%

Risk & Volitility

Alpha 11.23%
Beta 0.70
Sharpe Ratio0.91
Std Deviation 16.04%
Tracking Error 10.07%

About Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

The Tata India Pharma & Healthcare Fund Regular Growth has an AUM of 1338.85 crores & has delivered CAGR of 15.96% in the last 5 years. The fund has an exit load of 0.25% and an expense ratio of 2.10%. The minimum investment in Tata India Pharma & Healthcare Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 100.

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

The top holdings of the fund include Sun Pharmaceutical Industries, Max Healthcare Institute, Healthcare Global Enterprises & Abbott India.

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Chemical Manufacturing & Medical Equipment & Supplies.

Some of the similar funds are UTI Healthcare Fund Regular Plan Growth, Tata India Pharma & Healthcare Fund Regular Growth, Mirae Asset Healthcare Fund Regular Growth, Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, HDFC Pharma and Healthcare Fund Regular Growth. Tata India Pharma & Healthcare Fund Regular Growth has a sharpe ratio of 0.91 & a standard deviation of 16.04%.